Planned Parenthood Hudson Peconic Debuts Mobile Health Center
Planned Parenthood of Greater New York Statement on Supreme Court Oral Arguments: Mifepristone, Like Abortion, is Essential Health Care
As this case continues, mifepristone remains on the market and FDA-approved
Planned Parenthood of Greater New York Responds to Conviction Of Clinic Protestor For Violating The Freedom Of Access To Clinic Entrances Act Outside Manhattan Health Center
Yesterday, a unanimous jury found Bevelyn Beatty Williams of Tennessee unlawfully interfered with patients seeking, and medical professionals providing, reproductive health services outside Planned Parenthood of Greater New York’s Manhattan Health Center.
Planned Parenthood of Greater New York Expands Project Street Beat Harm Reduction Program to Mid-Hudson Valley
Planned Parenthood of Greater New York’s Project Street Beat program, which provides confidential, nonjudgmental harm reduction services to individuals who are living with or at risk for HIV or who have chronic health conditions, is expanding to the Mid-Hudson Valley.
PLANNED PARENTHOOD OF GREATER NEW YORK ON SUPREME COURT AGREEING TO HEAR MIFEPRISTONE CASE
As this case continues, mifepristone remains on the market and FDA-approved
A Second Report Reveals Youth with Intellectual Disabilities and Their Caregivers Need Greater Education on Diverse Topics of Sexuality
Results from the second report will help inform inclusive sex education for young people with ID, parents, caregivers, and professionals.
Planned Parenthood Hudson Peconic Now Offers Long-Acting HIV Prevention, Apretude
Planned Parenthood of Greater New York Announces Re-Opening of its Massapequa Health Center
On Tuesday, May 2nd Planned Parenthood of Greater New York opened its door to the newly renovated and thoroughly modernized, Massapequa health center.
Planned Parenthood of Greater New York Responds to SCOTUS Decision on Medication Abortion Case
This evening, the Supreme Court of the United States (SCOTUS) said that the abortion pill mifepristone would remain widely available for now, delaying the potential for a swift end to widespread availability of this medication that is used in more than half of abortions in the country.